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Epithelially-derived ameloblasts secrete extracellular matrix proteins including amelogenin,
enamelin, and ameloblastin. Complex intermolecular interactions among these proteins
are believed to be important in controlling enamel formation. Here we provide in vitro
and in vivo evidence of co-assembly and co-localization of ameloblastin with amelogenin
using both biophysical and immunohistochemical methods. We performed co-localization
studies using immunofluorescence confocal microscopy with paraffin-embedded tissue
sections frommandibular molars of mice at 1, 5, and 8 days of age. Commercially-available
ameloblastin antibody (M300) against mouse ameloblastin residues 107–407 and
an antibody against full-length recombinant mouse (rM179) amelogenin were used.
Ameloblastin-M300 clearly reacted along the secretory face of ameloblasts from days
1–8. Quantitative co-localization was analyzed (QCA) in several configurations by choosing
appropriate regions of interest (ROIs). Analysis of ROIs along the secretory face of
ameloblasts revealed that at day 1, very high percentages of both the ameloblastin
and amelogenin co-localized. At day 8 along the ameloblast cells the percentage of
co-localization remained high for the ameloblastin whereas co-localization percentage
was reduced for amelogenin. Analysis of the entire thickness on day 8 revealed
no significant co-localization of amelogenin and ameloblastin. With the progress of
amelogenesis and ameloblastin degradation, there was a segregation of ameloblastin and
co-localization with the C-terminal region decreased. CD spectra indicated that structural
changes in ameloblastin occurred upon addition of amelogenin. Our data suggest that
amelogenin-ameloblastin complexes may be the functional entities at the early stage of
enamel mineralization.
Keywords: ameloblastin, amelogenin, protein-protein co-assembly, confocal microscopy, quantitative co-
localization analysis
INTRODUCTION
Tooth enamel, the hardest substance in the body, is formed by
an evolutionarily highly conserved biomineralization process that
is controlled by extracellular matrix proteins. During the secre-
tory stage of enamel formation, the three major proteins secreted
by ameloblasts are amelogenin (Amel) (Snead et al., 1985),
ameloblastin (Ambn) (Krebsbach et al., 1996), and enamelin (Hu
et al., 2001a,b; Hu and Yamakoshi, 2003). Proper mineralization
of enamel depends upon the secretion of these proteins, as well
as their being processed into smaller functional components and
eventually degraded by proteinases such as enamelysin (matrix
metalloproteinase 20, Mmp-20) and kallikrein 4 (Klk4) (Bartlett
and Simmer, 1999). It was suggested that those proteins of enamel
must have specific protein–protein interactions to assemble an
organic matrix that is capable of undergoing mineral replacement
and forming the highly ordered three-dimensional structure of
the hydroxyapatite crystallites (Hu et al., 2001a; Bouropoulos
and Moradian-Oldak, 2004; Bartlett et al., 2006; Fan et al., 2008;
Iijima et al., 2010; Yang et al., 2011; Gallon et al., 2013). However,
there is still a gap in our knowledge as how these enamel matrix
components interact with one another to form an assembled
matrix that initiate and orchestrate the events of mineralization
(Paine et al., 2001; Yamakoshi et al., 2003; Ravindranath et al.,
2004). We have recently reported cooperative function of amelo-
genin and enamelin as well as their interactions using both in vitro
and in vivo strategies (Bouropoulos and Moradian-Oldak, 2004;
Fan et al., 2011; Yang et al., 2011; Gallon et al., 2013).
Ameloblastin is a member of the secretory calcium-binding
phosphoprotein (SCPP) family of proteins (Kawasaki and Weiss,
2003). It is a typical extracellular matrix (ECM) protein that may
be involved in the regulation of adhesion, proliferation, and dif-
ferentiation of ameloblasts (Fukumoto et al., 2004), and it seems
to serve essential developmental functions of enamel. Support
for this notion was provided by the finding that an enamel layer
fails to appear on the teeth of mice that are genetically engi-
neered to produce a truncated form of ameloblastin (exon 5 and
6 deleted) (Smith et al., 2009; Wazen et al., 2009). Inactivation
of the ameloblastin gene leads not only to loss of production of
the full-length protein by ameloblasts but also to a reduction in
the expression levels of amelogenin with no apparent change in
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the levels of other proteins (Fukumoto et al., 2004; Zalzal et al.,
2008).
A potential mechanisms by which ameloblastin functions as
an ECM protein in tooth enamel has been identified, including
involvement in mineralization by means of calcium-binding sites
at the C-terminus of ameloblastin (Yamakoshi et al., 2001; Hu
et al., 2005; Kobayashi et al., 2007; Tamburstuen et al., 2010).
Ameloblastin is rapidly processed after secretion. Full-length
ameloblastin is only found adjacent to the non-secretary face of
the Tomes’ processes of the ameloblasts (Uchida et al., 1995; Hu
et al., 1997; Murakami et al., 1997), while lower molecular weight
proteins are present in the sheath space and in the rods of the
superficial layer. The porcine N-terminal cleavage products (13,
15, 17 kDa) are stable and concentrate in the prism sheath. In
contrast, the C-terminal cleavage products (40, 50 kDa) are suc-
cessively cleaved into smaller peptides (8, 13, 15, 27, 29 kDa) and
lost from the immature enamel soon after secretion (Uchida et al.,
1998).
Our present study focuses on the co-localization of amelo-
genin and ameloblastin and their interactions. We propose that
such interactions are important for the formation of highly
organized enamel mineral and for maintaining its prismatic
structure. We hypothesized that, by analyzing the spatial co-
relation between ameloblastin and amelogenin in the enamel
matrix using a well-established in vivo approach, complemented
by investigating the interaction between full-length ameloblastin
and amelogenin using in vitro experiments, we will gain new
and important information on the roles played by ameloblastin-
amelogenin complexes in normal dental enamel formation.
We used immunofluorescence confocal microscopy with mouse
mandibular first molars at differing postnatal ages (P1, P5, and
P8) and two antibodies to ascertain when both ameloblastin
and amelogenin are secreted into the ECM of enamel, as well
as whether they are co-localized, which would support the
possibility of their interaction in vivo. Commercially available
antibody against 107–407 residues of mouse ameloblastin and
an antibody against the full-length recombinant mouse (rM179)
amelogenin were used in this procedure (Simmer et al., 1994).
Direct in vitro evidence of structural changes in ameloblastin




Two primary antibodies were used in this study, (i) rabbit anti-
ameloblastin (M300), commercially available antibody against
the portion of mouse ameloblastin extending from residues
107–407 (Figure 1A, residues labeled with blue) (Santa-Cruz
Biotechnology, Inc. Santa Cruz, California) and (ii) chicken anti-
amelogenin generated against full-length mouse amelogenin (a
gift from Prof M. Snead). For immunohistochemical staining
two secondary antibodies were used (i) goat anti-rabbit conju-
gated with Texas Red and (ii) bovine anti-chicken conjugated with
FITC (fluorescein isothiocyanate) (Santa-Cruz Biotechnology,
Inc. Santa Cruz, California).
We checked whether there was any cross-reaction between
antibodies and the proteins, by using Western blot with
recombinant mouse amelogenin and ameloblastin (Figures 1B,C,
lane 4-5). Samples were electrophoresed on 10 % polyacry-
lamide gel containing 0.1% sodium dodecyl sulfate (SDS-PAGE)
under non-reducing conditions and then electrotransferred to
polyvinylidene fluoride (PVDF)membranes (PALL, Life Sciences,
BioTrace™ PVD 0.45μm) in semi-dry transblotter (Bio-Rad
Scientific Instruments) at 10V for 45min. After blocking with
phosphate-buffered saline, 0.1% Tween 20 (PBST) (pH 7.4) with
5% non-fat milk for 2 h at 37◦C, the membrane was washed five
times with PBST. After washing, themembranes were treated with
the primary antibody (M300, rabbit anti-ameloblastin) against
FIGURE 1 | (A) Sequence of full-length mouse ameloblastin (Gene ID: 11698), the epitope of anti-ameloblastin antibody M300 is indicated by blue color. Western
blot analysis with (B) anti-amelogenin antibody (lane 3, 4) and (C)M300 antibody (lane 3, 4) to check cross reactivity of the antibodies with recombinant proteins.
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mouse ameloblastin at a 1:1000 dilution overnight at 4◦C. After
five washes, themembranes were incubated for 2 h in anti-chicken
(for amelogenin) and anti-rabbit (for ameloblastin) secondary
antibody conjugated with horseradish peroxidase at an appro-
priate dilution (1:3000). After another wash, the membranes
were incubated in Amersham™ ECL Western blotting detection
reagents (GE healthcare). In lane 4 from Figures 1B,C, there was
no protein band, demonstrating that the both ani-amelogenin
and M300 antibody did not react with recombinant ameloblastin
and amelogenin respectively.
PROTEIN EXPRESSION AND PURIFICATION
Preparation of the recombinant rM179 has been described else-
where (Moradian-Oldak et al., 2000; Lakshminarayanan et al.,
2010). The protein was further purified on a Jupiter C4 semi-
preparative reversed phase column (10 × 250mm, 5μm) Varian
Prostar HPLC system (ProStar/Dynamics 6, version 6.41, Varian,
Palo Alto, CA). A linear gradient of 60% acetonitrile in 0.1% tri-
fluoroacetic acid at a flow rate of 2ml/min was used (Figure 1B,
lane 2).
Recombinant porcine amelogenin (rP172) was expressed
in Escherichia coli strain BL21-codon plus (DE3-RP, Agilent
Technologies, Inc., Santa Clara, CA), precipitated by 20% ammo-
nium sulfate and purified as previously described (Hu et al., 1996;
Ryu et al., 1999). The precipitate was dissolved in 0.1% TFA and
protein purification was accomplished on a reverse phase C4 col-
umn (10 × 250mm, 5μm) mounted on a Varian Prostar HPLC
system (ProStar/Dynamics 6, version 6.41Varian, Palo Alto, CA)
and fractionated using a linear gradient of 60% acetonitrile at a
flow rate of 1.5mL/min.
Recombinant murine ameloblastin (rMAmbn) both phospho-
rylated and glycosylated (Figure 1C, lane 2) was prepared in a
Drosophila melanogaster expression system using Schneider 2
cells (Invitrogen, CA) as previously described (Zeichner-David
et al., 2006). The protein was purified by HPLC with a gradient
of 20–80% B for 60min (buffer B was 60% v/v aqueous acetoni-
trile in 0.1% v/v trifluoroacetic acid (TFA) and buffer A was 0.1%
TFA) at a flow rate of 1.0ml/min.
Sodium dodecyl sulfate–polyacrylamide gel electrophoresis
(SDS–PAGE) was carried out in the presence of 0.1% SDS, using
a 10% acrylamide gel (Laemmli, 1970) to characterize the pro-
teins (Figures 1B,C). The gel was stained with Coomassie brilliant
blue.
IMMUNOCHEMICAL ANALYSIS OF PROTEIN FROM ENAMEL
EXTRACELLULAR MATRIX AT DAY 9
For immunochemical analyses, six 9-day-old (postnatal) mice
were used. All mouse studies were conducted according to
protocols approved by the USC Institutional Animal Care & Use
Committee. The upper and lower molars were extracted from
the alveolar bone. The enamel surface was then gently wiped
to remove remnants of secretory ameloblasts. The sample was
dissolved in 0.5M acetic acid (four molar /100μl) and dissolu-
tion is aided by grinding the samples in the acid with pestle and
then total extracted protein was lyophilized. Samples were elec-
trophoresed on 10 % polyacrylamide gel containing 0.1% sodium
dodecyl sulfate (SDS-PAGE) under non-reducing conditions and
thenWestern blot analysis was performed as described in previous
Section using both anti-amelogenin and M300 primary antibody
(Figure 2, lane 2, 3).
TISSUE PREPARATION
Mandibular processes of mice from postnatal days 1–8 (here the
day of birth was termed postnatal day 0) were dissected and fixed
in 4% paraformaldehyde in PBS at pH 7.4 for 24 h. Samples from
day 5–8 were demineralized in 0.2% paraformaldehyde, 0.05%
glutaraldehyde and 10% EDTA for ∼1–2 weeks (pH 8.0) at 4◦C
with rocking. The tissues were then processed for histological
analysis and embedded in paraffin. Tissue sections of 7μm thick-
ness were cut from the wax blocks and mounted onto glass slides.
IMMUNOFLUORESCENCE LABELING
Tissue sections were subjected to an antigen retrieval step by incu-
bation in 10mM sodium citrate with 0.05%Tween 20 at pH 6.0 in
a 60◦C water bath overnight. The sections were allowed to cool in
dH2O before being rinsed in TBS and then incubated with 0.3%
H2O2 for 15min. After washing with TBS, sections were blocked
with 1% bovine serum albumin (BSA) for 15min before incu-
bation overnight at room temperature with primary antibody.
We have used 1:500 dilutions for anti-ameloblastin M300 and
1:1000 for anti-amelogenin (Section Description of Antibodies).
For simultaneous immunofluorescence double-labeling mixture
of both primary antibodies with above mentioned dilution were
used. After another wash with TBS, sections were incubated with
secondary antibody (for ameloblastin goat anti-rabbit-Texas Red
and for amelogenin bovine anti-chicken-FITC with 1:100 dilu-
tion each) for 3 h at room temperature, before mounting with
FIGURE 2 | Immunochemical detection of amelogenin (lane 2) and
ameloblastin (lane 3) proteins and their degradation products present
in enamel matrix from postnatal day 9 old (P9) mouse enamel.
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Vectashield® Hard Set™ mounting medium with DAPI. Similar
to primary antibody we have used mixture of both secondary
antibodies for immunofluorescence double-staining. Several con-
trols were performed to ascertain the specificity of the antibodies,
which included incubating each primary antibody with both sec-
ondary antibodies, as well as each secondary antibody with both
primary antibodies. The sections were visualized using a Leica
TCS SP5 confocal microscope.
QUANTIFICATION OF CO-LOCALIZATION OF TWO ANTIGENS
Using the Leica Application Suite Advanced Fluorescence soft-
ware (version 2.5.2.6939) confocal images were analyzed with a
threshold of each channel at 30% and a background correction
of 20%, and scatter grams were generated. Mander’s colocaliza-
tion coefficients were calculated to predict the contribution of
each particular antigen to the areas with co-localization, using the









when, Ri, coloc = Ri if Gi > 0; Gi, coloc = Gi if Ri > 0, i.e., Mred is
the sum of intensities of red pixels that have a green component
divided by the total sum of red intensities.
CIRCULAR DICHROISM
CD measurements were carried out at 37◦C on a JASCO J-715
spectropolarimeter between 190 and 260 nm in a quartz cell with
a path length of 1mm. Four spectra were accumulated for each
sample, and the contribution of the buffer was always subtracted.
Data are represented as mean residue ellipticities. Stock solution
of rP172 (89% analogues to mouse amelogenin) was prepared in
distilled water and rMAmbn was prepared in Tis-HCL pH 8.0.
CD experiments were performed with 10μM protein in 10mM
potassium phosphate buffer at pH7.4. CD spectra were normal-
ized to the protein concentration and normalized spectra were
deconvoluted using the CDSSTR algorithm and the Reference
set 7 at Dichroweb (Lobley et al., 2002; Whitmore and Wallace,
2004). The values for helix1 and helix2 as well as sheet1 and sheet2
were added to obtain total helix and total sheet content (Sreerama
et al., 1999).
RESULTS
DEGRADATION AND DISTRIBUTION OF MOUSE AMELOBLASTIN
We analyzed the degradation of mouse ameloblastin immuno-
chemically using Western blot analysis (Figure 2, lane 3) with
proteins extracted from 9 day old mouse enamel. In the
enamel matrix sample, M300 antibody reacted with protein
bands having molecular weights of near 62, 40, 33, and 29 kDa
(Figure 2, lane 3). The largest 62 kDa band corresponds to the
nascent ameloblastin and the others are presumably C-terminal
ameloblastin processing products (Uchida et al., 1997, 1998;
Brookes et al., 2001).
To observe the distribution of ameloblastion and its prote-
olytic products in enamel we have incubate tissue sections from
day 1 (Figure 3A), 5 (Figure 3B) and 8 (Figure 3C) with anti-
ameloblastin M300 antibody followed by immunofluorescence
FIGURE 3 | Confocal images of mouse molar enamel showing
immunofluorescence of ameloblastin at postnatal days (A) P1, (B) P5
and (C) P8. (D) Represents the immunofluorescence of amelogenin at P8.
Nuclei are stained with DAPI (blue).
labeling with Texas red conjugated anti-rabbit secondary
antibody (see Section Description of Antibodies and
Immunofluorescence Labeling). Confocal image of the sec-
tion at postnatal day 1(P1) indicated that M300 antibody stained
the distal cytoplasm of ameloblasts, particularly in Tomes’
processes and immature enamel near the secretory surfaces of
pre-secretoty ameloblasts (Figure 3A). During the early mat-
uration stage when the degradation of ameloblstin has already
started, at day 5 (P5), they were present in the enamel epithelium
and at the enamel surface (Figure 3B). At day 8 (P8), we observed
that M300 reacted with the proteins which were accumulated in
the juxtanuclear cytoplasm, the distal cytoplasm near the enamel
surface, at the enamel surface and dentino-enamel junction
(Figure 3C) (Lee et al., 1996).
The immunofluoresence study at P8 (Figure 3C) with M300
antibody gives us a clear picture of localization pattern of
ameloblastin and its C-terminal processing products which
were identified by immunochemical analysis (Figure 2, lane 3).
Figure 3D shows the localization pattern of amelogenin and
its processing products (Figure 2, lane 2) at day P8. The anti-
amelogenin antibody stained evenly across the enamel layer
(visualized by green color FITC conjugated secondary antibody).
THE CO-LOCALIZATION PATTERN OF Ambn AND Amgn IN MOUSE
MANDIBULAR MOLARS
To visualize the co-localization of ameloblastin and amelogenin
and for further confirmation of distribution of these two pro-
teins in enamel extracellular matrix we acquired confocal images
of tissue sections (simultaneously immunostained with two flu-
orophore mixture) at P1 (Figure 4A), P5 (Figure 4B) and P8
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(Figure 4C). In Figure 4 the regions which were yellow or orange
in color represent the co-localization of both the protein. Next
quantitative co-localization analysis (QCA) was performed using
fluorescence software to quantify the percentage of co-localization
of Ambn and Amgn at P1 and P8 (Figures 5, 6) using selected
region of these images (Figure 4, for P5 data not shown) with
higher magnification.
QCA was conducted at day 1 using a selected co-localization
region from Figure 4A (white square), which presented in
Figure 5A. We have divided this co-localization region (yellow
colored) into 14 small regions of interest (ROIs) and the direc-
tion of analyzed region of interest in Figure 5 is indicated by
pink arrow along the secretory face of the ameloblast (at the
enamel surface) from the cervical loop to tip of the molar. Then
Mander’s co-localization coefficients were calculated to charac-
terize the degree of overlap between two channels (Figure 5B,
green for Amgn and Figure 5C, red for Ambn) in the image
and to predict the contribution of each particular antigen to the
FIGURE 4 | Co-localization patterns (yellow color) of ameloblastin and amelogenin within the forming enamel layer of mouse mandibular molar
sections at (A) P1, (B) P5 and (C) P8. Amelogenin and ameloblstin simultaneously co-labeled with FITC (green) and with TR (red) respectively.
FIGURE 5 | Quantitative co-localization of ameloblastin and amelogenin
in mouse molar enamel at P1. (A) Confocal image with higher
magnification taken from the sample in Figure 4A (see square), considered
for QCA analysis along the enamel surface (pink arrow). The individual
channels detecting (B) only Amgn and (C) only Ambn signal. (D) Represent
the pixels that have only co-localizing signal after threshold and background
corrections of image (A). (E) Graph of total intensity sum of each fluophore.
(F) Plot of Mander’s co-localization coefficient with respect to region of
interest as shown in (D). Each ROI dimension (5 × 5μm). Note that ROI 1 to
14 in (E,F) correspond to the pink arrow in (A).
www.frontiersin.org July 2014 | Volume 5 | Article 274 | 5
Mazumder et al. Amelogenin-ameloblastin co-localization
FIGURE 6 | Quantitative co-localization of ameloblastin and amelogenin
in mouse molar enamel at P8. (A) Confocal image with higher
magnification taken from the sample in Figure 4C (see square), considered
for QCA analysis along the enamel surface (pink arrow) and enamel thickness
(cyan arrows). The individual channels detecting (B) only Amgn and (C) only
Ambn signal. (D) Represents co-localization pattern after analysis of image
(A) with threshold and background correction of each channel.
(E) Represents the intensity sum of each fluophore at each region of interest.
(F) Plot of Mander’s co-localization coefficient with respect to region of
interest as shown in (D). Each ROI dimension (10 × 10μm). Note that (E1,F1)
correspond to pink arrow in (A) and (E2,F2) correspond to cyan arrow in (A)
(Enamel 1), and (E3,F3) correspond to cyan arrows (Enamel 2).
areas with co-localization, which is the number of pixels that
have a co-localizing signal (Figure 5D, represented by white dots).
First the values for signal intensity sum of the green channel
(Figure 5E, green line), red channel (Figure 5E, red line) and the
co-localization intensity (data not shown) were generated at each
ROI. Then the co-localization intensity was divided by the signal
intensity to obtain co-localization coefficients (Figure 5F), which
measured the proportion of overlap of each channel with the
other. As can be seen from the co-localization coefficient graph,
at the initial stage of enamel development (P1), Amgn and Ambn
co-localized near the secretory face of ameloblasts with almost the
same proportion and high coefficient values (Figure 5F).
On day 8, QCA was performed with a section of Figure 4C
(square or inset), represented in Figure 6A. At P8 the enamel
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was more mature, we have calculated co-localization coefficients
in two different configurations, one along the secretory face of
the ameloblast from the cervical loop to tip of the molar (at
the enamel surface indicated by pink arrow) and two along the
thickness of the enamel layer from the enamel surface to dentino-
enamel junction (indicated by cyan blue arrows as Enamel1 and
Enamel2) (Figure 6A). The two individual channels of this confo-
cal image were presented by Figure 6B (green channel for Amgn)
and Figure 6C (red channel for Ambn) and the number of pix-
els that have a co-localizing signal in same image indicated by
white dots in Figure 6D. We have calculated the total sum of green
(Figure 6E, green line) and red (Figure 6E, red line) intensities
along, (i) the ameloblast (Figure 6E1) and (ii) enamel thick-
ness (Figures 6E2,E3). We observed that at day 8 the intensity
difference between the two channels increased in both config-
urations (Figures 6E1–E3) relative to day 1 (Figure 5E). The
co-localization coefficient plot at P8 indicated that Ambn co-
localized with Amgn along the secretory face of ameloblasts, and
their proportions of co-localization differed (Figure 6F1). There
was a higher percentage of Ambn co-localizing with Amgn than
Amgn co-localizing with Ambn. Along the enamel thicknessmov-
ing award from the ameloblasts, no significant co-localization was
observed (Figures 6F2,F3).
It appears that at an early stage both antigens (ameloblastin
and amelogenin) are distributed in the same region with high spa-
tial overlap, i.e., we can assume that they may be close enough to
form co-assemblies, but with maturation ameloblastin has a high
co-localization coefficient in comparison to amelogenin.
This trend can be clearly seen when the average of the co-
localization coefficients for each age is calculated and plotted
(Figure 7A). We have calculated the ratio of the total intensity
sum of Ambn-red channel (
∑
i Ri) to the Amgn-green chan-
nel (
∑
i Gi) of each region of interest (Figures 5E, 6E) along
the enamel surface obtained from confocal images of day 1 and
8 mouse mandibular molars (Figure 7B). At an early develop-
mental stage (day 1) we found that the ratio gradually reaches
the value 1 when moving from the root to the tips of the tooth
(Figure 7B, black line), which indicates that the proteins were
secreted simultaneously and in similar proportions (calculated
from QCA) from ameloblasts (Zalzal et al., 2008). With enamel
maturation, at day 8 the intensity ratio decreases (Figure 7B, red
line), indicating that at the maturation stage, ameloblastin and its
proteolytic products (C-terminal large soluble polypeptides) (Lee
et al., 1996; Uchida et al., 1997, 1998; Brookes et al., 2001) are
gradually lost from the enamel surface.
Our co-localization studies suggested that amelogenin-
ameloblastin complexes may be the functional entities at the
early stage of enamel mineralization. In order to examine how
amelogenin would affect ameloblastin’s structure, we performed
in vitro experiment, e.g., CD spectroscopy study with recombi-
nant proteins.
CD SPECTROSCOPIC STUDY OF Ambn AND Amgn INTERACTION
CD spectra analysis of Ambn (10μM) in the presence of equimo-
lar Amgn revealed that Amgn induced changes in the sec-
ondary structure of Ambn (Figure 8). The CD spectrum of
rMAmbn at 37 ◦C, with a negative minima around 208 nm
and a small negative shoulder around 227 nm, is characteristic
of an unordered structure (βII structure) (Figure 8, black solid
line). Additionally, the spectra deconvolution shows rMAmbn
contain intermixed alpha-helical (24%), beta-sheet (24%) and
beta-turn (18%) regions with 34% unordered structure. The
human recombinant full-length ameloblastin also exhibited βII
like structural property at 37◦C (Wald et al., 2011, 2013) and
almost similar deconvolution pattern with less helical content
and more beta character. With the addition of equimolar Amgn
to Ambn, we observed an isoelliptic point appears at around
211 nm and a distinct change in CD bands. The intensity of the
shoulder around 224 nm became more negative and at 192 nm
a positive maxima was appeared. The spectral deconvolution
exhibited the alpha-helical content increased to 51% and the beta-
sheet, beta-turn and unordered forms decreased to 17, 12, and
14%, respectively. To avoid the interference of Amgn’s structural
changes on Ambn due to its self-association at high concen-
trations (>62.5μM) (Lakshminarayanan et al., 2007), we used
a very low concentration of Amgn (10μM) and also we have
FIGURE 7 | Comparison of (A) the differences in the average co-localization coefficients of Amgn and Ambn at P1 and P8 and (B) intensity ratio of
total sum of intensities of red to green channels of each region of interest along the enamel surface.
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FIGURE 8 | Structural changes of ameloblastin (Ambn) in the presence
of amelogenin (Amgn) provide evidence for their co-assembly. Far-UV
circular dichroism (CD) spectra of 10μM rMAmbn only (solid line) and in the
presence of 10μM rP172 (dashed line).
subtracted its contribution from the CD spectra of equimolar
mixture of both the proteins. The structural changes in Ambn
at this low Amgn concentration thus clearly indicated that the
proteins formed hetero-assemblies.
DISCUSSION
Amelogenin and ameloblastin, the major enamel matrix proteins,
are important for well-orchestrated enamel biomineralization
(Snead et al., 1985; Krebsbach et al., 1996). They have synergis-
tic roles in enamel development, as suggested by recent study
showing that Amel X−/− /Ambn−/− mice have additional enamel
defects not observed in either Amel X−/− or Ambn−/− mice
(Hatakeyama et al., 2009). The co-distribution of amelogenin
and ameloblastin in the majority of the secretory granules in
Tomes’ processes during appositional growth of the enamel layer
may reflect a form of functional association between these two
distinct proteins (Zalzal et al., 2008). There is in vitro evidence
of interactions between amelogenin (tyrosyl-binding motif) and
ameloblastin (Ravindranath et al., 2004). The same group further
produced some indications that during early tooth development
the murine ameloblastin 37 kDa isoform interacts with amelo-
genin (Ravindranath et al., 2007). However, there still remains
a gap in our knowledge of how these proteins are distributed
in the extracellular enamel matrix, what the contribution pat-
tern of each particular protein is to the areas with co-localization
during the different stages of tooth development, and also what
structural changes occur when amelogenin and ameloblastin
co-assemble.
In order to give clear insight into the putative cooperative
function of ameloblastin and amelogenin we took advantage of
quantitative co-localization techniques and performed a system-
atic analysis of the localization of ameloblastin with respect to
amelogenin in the mouse mandibular molar. We performed an
additional in vitro study using circular dichroism (CD) spec-
troscopy to show the structural changes in ameloblastin when
it co-assembles with amelogenin. We concentrated on confocal
images from mandibular first molars from postnatal mice from
one to eight days old (here the day of birth was termed postnatal
day 0). Previous research into the expression of ameloblastin
and amelogenin by in situ hybridization using DNA biotinylated
probes (Torres-Quintana et al., 2005) has indicated that mRNA
expression of ameloblastin and amelogenin in mouse molars is
first observed in pre-ameloblasts at the tip of the cusp at post-
natal day 2 for ameloblastin and day 3 for amelogenin (the day
of birth was considered as postnatal day 1) and that expression of
both proteins was seen until amelogenin expression terminated in
maturation-stage ameloblasts at postnatal day 10. In our present
study we used samples up to postnatal day 8 to ensure that both
amelogenin and ameloblastin will be present (Figures 3A–D).
The present study showed that secretion of amelogenin and
ameloblastin starts at the cuspal slopes of molars, as seen on
postnatal day 1 (Figures 3A, 4A, 5A). We observed that secre-
tion continues until at least postnatal day 8 (Figures 3C, 4C, 6A).
This is in agreement with the study of mRNA expression of
ameloblastin (Torres-Quintana et al., 2005) but amelogenin was
observed here earlier than the first detection of mRNA expres-
sion of amelogenin in the previous study. This difference could be
explained by individual difference between mice and their strains.
Quantitative co-localization analysis is potentially a power-
ful tool for studying extracellular matrix protein interactions, as
spatially related proteins have a high probability of interacting.
Moreover, significantly more data can be generated while elim-
inating bias and errors of visual interpretation (Costes et al.,
2004). In a recent report (Gallon et al., 2013) we have used confo-
cal microscopy to successfully determine co-localization between
amelogenin and enamelin in enamel extracellular matrix.
We utilized the Mander’s co-localization coefficients M1 and
M2 as these coefficients are not dependent upon the intensities
of the signals and can compare signal intensities for different
fluorophores when their signal intensities differ (Manders et al.,
1993). These coefficients give a measure of the amount of fluores-
cence of the co-localizing objects of the image relative to the total
fluorescence. By plotting the co-localization co-efficients Mgreen
and Mred of amelogenin or ameloblastin against the regions of
interest, patterns of co-localization were revealed and compar-
isons weremade. The use of an antibody against ameloblastinmay
allow us to detect the full-length protein as well as its proteolytic
products containing that epitopes. Such products may include the
equivalent to the reported rat ameloblastin proteolytic products
(Uchida et al., 1997, 1998; Brookes et al., 2001). While the pat-
tern of proteolysis of porcine ameloblastin is well documented
(Chun et al., 2010), information regarding the rodent proteolytic
pattern is limited. Here the 62, 40, 33, and 29 kDa products were
detected byWestern blot analysis of protein extracted from 9-day-
old mice (Figure 2, lane 3). We followed the migration pattern
of proteolytic products from the ameloblastin C-terminal in the
ECM at day 8. It is notable that signals for amelogenin and/or
ameloblastin were not so prominent within the ameloblasts.
Following their secretion and processing by MMP-20, epitopes
on both amelogenin and ameloblastin can be more available for
interaction with the antibody in the ECM.
As seen in Figure 7A, the proportion of co-localization
between ameloblastin and amelogenin varies with the postnatal
age of the mouse. At early stages, when enamel is initially devel-
oping, the proteins co-localize with each other to a large degree
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and in the same proportions (Figure 5F). Since we observe that
the contribution of each antigen to the areas with co-localization
is high, i.e., ameloblastin and amelogenin strongly overlap with
each other at day 1, we interpret the data to suggest that at
initial stages of enamel development they co-assemble. With
enamel maturation this pattern changes. For a time, on day 8,
the proportion of co-localizing ameloblastin remain greater than
the proportion of co-localizing amelogenin, indicating there is
now more “free” or non-co-localizing amelogenin than “free”
ameloblastin. This also indicates that there is more amelogenin
present in the extracellular matrix than ameloblastin at later
stages, which is verified by plotting the intensity ratio with age
(Figure 7B). These findings are in accordance with the pub-
lished report that the C-terminal polypeptides of ameloblastin
are successively cleaved into smaller peptides and lost from the
extracellular matrix (Uchida et al., 1997, 1998) at maturation
stage. Co-localization of amelogenin proteolytic products and
ameloblastin N-terminal is possible and it is a subject of ongoing
investigation (Mazumder et al., in preparation).
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